HSBC Holdings’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-386,006
| Closed | -$45.5M | – | 3182 |
|
|
2021
Q1 | $45.5M | Sell |
386,006
-15
| -0% | -$1.77K | 0.05% | 346 |
|
|
2020
Q4 | $45.5M | Buy |
386,021
+120,493
| +45% | +$14M | 0.06% | 309 |
|
|
2020
Q3 | $29.5M | Sell |
265,528
-2,133
| -0.8% | -$229K | 0.05% | 354 |
|
|
2020
Q2 | $27.4M | Sell |
267,661
-120,611
| -31% | -$12.9M | 0.05% | 339 |
|
|
2020
Q1 | $41.9M | Sell |
388,272
-6,660
| -2% | -$765K | 0.1% | 195 |
|
|
2019
Q4 | $45.8M | Sell |
394,932
-476,765
| -55% | -$55.2M | 0.08% | 244 |
|
|
2019
Q3 | $99.8M | Sell |
871,697
-234,939
| -21% | -$23.4M | 0.19% | 100 |
|
|
2019
Q2 | $105M | Sell |
1,106,636
-326,975
| -23% | -$30.8M | 0.2% | 101 |
|
|
2019
Q1 | $131M | Buy |
1,433,611
+21,123
| +1% | +$1.73M | 0.24% | 77 |
|
|
2018
Q4 | $107M | Sell |
1,412,488
-72,351
| -5% | -$5.32M | 0.2% | 96 |
|
|
2018
Q3 | $119M | Buy |
1,484,839
+780,455
| +111% | +$72.7M | 0.19% | 100 |
|
|
2018
Q2 | $70M | Buy |
704,384
+23,448
| +3% | +$2.03M | 0.12% | 143 |
|
|
2018
Q1 | $55.2M | Buy |
680,936
+45,564
| +7% | +$3.68M | 0.08% | 234 |
|
|
2017
Q4 | $50M | Buy |
635,372
+592,249
| +1,373% | +$49.2M | 0.07% | 250 |
|
|
2017
Q3 | $3.98M | Sell |
43,123
-144,461
| -77% | -$13.9M | 0.01% | 1113 |
|
|
2017
Q2 | $21.2M | Buy |
187,584
+34,540
| +23% | +$3.86M | 0.04% | 488 |
|
|
2017
Q1 | $15.3M | Buy |
+153,044
| New | +$16.4M | 0.03% | 554 |
|
|
2016
Q2 | – | Sell |
-50,000
| Closed | -$5.72M | – | 2232 |
|
|
2016
Q1 | $5.72M | Hold |
50,000
| – | – | 0.02% | 845 |
|
|
2015
Q4 | $7.12M | Hold |
50,000
| – | – | 0.02% | 808 |
|
|
2015
Q3 | $4.49M | Hold |
50,000
| – | – | 0.01% | 848 |
|
|
2015
Q2 | $5.76M | Hold |
50,000
| – | – | 0.01% | 785 |
|
|
2015
Q1 | $4.78M | Hold |
50,000
| – | – | 0.01% | 921 |
|
|
2014
Q4 | $3.36M | Sell |
50,000
-1,185
| -2% | -$73.4K | 0.01% | 1017 |
|
|
2014
Q3 | $2.76M | Sell |
51,185
-44,823
| -47% | -$2.21M | 0.01% | 1065 |
|
|
2014
Q2 | $4.27M | Sell |
96,008
-53,992
| -36% | -$2.21M | 0.01% | 893 |
|
|
2014
Q1 | $5.2M | Hold |
150,000
| – | – | 0.01% | 789 |
|
|
2013
Q4 | $4.33M | Hold |
150,000
| – | – | 0.01% | 895 |
|
|
2013
Q3 | $4.38M | Hold |
150,000
| – | – | 0.01% | 876 |
|
|
2013
Q2 | $3.44M | Buy |
+150,000
| New | +$3.79M | 0.01% | 792 |
|
HSBC Holdings's CBPO Position: Q2 2021 in Review
HSBC Holdings sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 386,006 shares — an estimated $45.5M sold.
HSBC Holdings first reported a position in CBPO in Q2 2013 and held it in 29 quarters. The position peaked at $131M in Q1 2019. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- HSBC Holdings reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- HSBC Holdings sold 386,006 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $45.5M.
- HSBC Holdings first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and held it in 29 quarters.
- HSBC Holdings's China Biologic Products Holdings, Inc. position peaked at $131M in Q1 2019.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on HSBC Holdings's 13F filing for Q2 2021, filed 13 Aug 2021.